Click Therapeutics, Motivista, CT-155, FDA, 510(k), Digital Therapeutic, Prescription Digital Therapeutic, PDT, Schizophrenia, Negative Symptoms, Avolition

NEW YORK — October 5, 2026 Click Therapeutics, Inc. announced that the U.S. FDA has granted 510(k) clearance for...